Change search
ReferencesLink to record
Permanent link

Direct link
Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study.
Show others and affiliations
2005 (English)In: Circulation, ISSN 1524-4539, Vol. 111, no 15, 1924-31 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2005. Vol. 111, no 15, 1924-31 p.
Keyword [en]
Aged, Atenolol/therapeutic use, Body Mass Index, Body Weight, Cardiovascular Diseases/drug therapy/etiology/*physiopathology, Female, Humans, Hypertension/drug therapy/*physiopathology, Hypertrophy; Left Ventricular/drug therapy/*physiopathology, Losartan/therapeutic use, Male, Middle Aged, Obesity, Proportional Hazards Models, Risk Assessment, Somatotypes/*physiology
URN: urn:nbn:se:umu:diva-6287DOI: doi:10.1161/01.CIR.0000161799.91577.0APubMedID: 15837945OAI: diva2:145956
Available from: 2007-12-08 Created: 2007-12-08 Last updated: 2011-01-12Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Lindholm, Lars H
By organisation
Family Medicine

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 27 hits
ReferencesLink to record
Permanent link

Direct link